The global adrenomyeloneuropathy (AMN) treatment market is gaining momentum, supported by the rapid expansion of the neurodegenerative disease sector. The neurodegenerative disease market is projected to grow at a CAGR of 6.80% during 2025–2034, creating strong growth opportunities for AMN therapies worldwide. https://www.expertmarketresearch.com/reports/adrenomyeloneuropathy-treatment-market